Breaking News

Thermo Fisher Expands Steriles Facility in Asia-Pacific Region

Enables Singapore’s science and technology sector to accelerate R&D development and manufacturing.

Thermo Fisher Scientific has opened a new sterile drug facility in Singapore to support customers to deliver new medicines and vaccines in the Asia-Pacific market. The new facility marks a significant milestone and investment in pandemic preparedness for Singapore, which is fast emerging as a biomedical hub in the Asia-Pacific region. With help from the Singapore Economic Development Board (EDB), in alignment with the government’s investment in preparedness for future health emergencies, the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters